Overview
Compare with DUOS TECHNOLOGIES GROUP, INC., Great Elm Group, Inc. or zSpace, Inc., or pick any stock.
- TickerQXL on Nasdaq2
- IndustryServices-Prepackaged Software2
- HeadquartersTel Aviv, Israel2
- Incorporated inDE3
- Business address2 Jabotinsky St, Atrium Tower, 18Th Floor, Ramat Gan, 52529033
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI875500QG4CQ9A6A2IO662
- StatusActive2
- LEI statusIssued and current2
- Registered address16192 COASTAL HWY, 19958 Lewes, United States2
- Registered withDivision of Corporations, Department of State, 20691412
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
-3.1%Operating margin5
-44.7%Net margin5
-66.2%Revenue growth, 20246
-208.9%Return on equity5
0.09×Debt to equity5
$1.5MFree cash flow6
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Search brought in 98% of the revenue QUANTUM X LABS INC. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Search | $5.0M | $1.5M |
| Adjustments and Eliminations | $26.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Research and development3¢$830.0K
- Other costs96¢$26.0M
- Income tax0¢$131.0K
Out of $26.9M in revenue.65 The company lost money this year.
Where each dollar of operating cash went, fiscal 2024
- Capital spending0¢$1.0K
- Kept or used elsewhere100¢$1.5M
Out of $1.5M of cash from operations.6
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $1.6M | $5.0M |
| Traffic-acquisition and related costs | $297.0K | $1.7M |
| Research and development | $69.0K | $830.0K |
| Selling and marketing | $100.0K | $309.0K |
| General and administrative | $1.6M | $1.9M |
| Depreciation and amortization | $848.0K | $813.0K |
| Other expenses, net | $814.0K | $271.0K |
| Operating loss | $2.2M | $837.0K |
| Financial expense, net | $11.3M | $2.6M |
| Loss from continuing operations, before taxes | $13.4M | $3.4M |
| Income tax expense (benefit) | -$39.0K | $131.0K |
| Net loss from discontinued operations | $7.4M | $10.5M |
| Net loss | $20.8M | $14.1M |
| Less: net loss attributable to non-controlling interests | $1.5M | $2.1M |
| Net loss attributable to shareholders of Viewbix Inc. | $19.3M | $12.1M |
| Shareholders of Viewbix Inc. | $13.4M | $3.6M |
| Net loss from continuing operations | $13.4M | $3.6M |
| Shareholders of Viewbix Inc. | $5.9M | $8.5M |
| Non-controlling interests | $1.5M | $2.1M |
| Net loss per share from continuing operations - Basic attributed to shareholders | $2 | $1 |
| Net loss per share from continuing operations - Diluted attributed to shareholders | $2 | $1 |
| Net loss per share from discontinued operations - Basic attributed to shareholders | $1 | $2 |
| Net loss per share from discontinued operations - Diluted attributed to shareholders | $1 | $2 |
| Total net loss per share - Basic attributed to shareholders | $2.28 | $2.69 |
| Total net loss per share - Diluted attributed to shareholders | $2.28 | $2.69 |
| Weighted average number of shares - Basic | 8.5M shares | 4.5M shares |
| Weighted average number of shares - Diluted | 8.5M shares | 4.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.0M | $24.0K | ||
| Restricted deposits | $20.0K | $30.0K | ||
| Accounts receivable | $315.0K | $557.0K | ||
| Loan to parent company | $4.0M | |||
| Other current assets | $299.0K | $775.0K | ||
| Current assets of discontinued operations | $2.4M | |||
| Total current assets | $1.7M | $7.8M | ||
| Deferred taxes | $12.0K | $56.0K | ||
| Property and equipment, net | $56.0K | $17.0K | ||
| Financial assets measured at cost method | $600.0K | |||
| Intangible assets, net | $2.0M | $1.9M | ||
| Goodwill | $6.4M | $1.1M | ||
| Non-current assets of discontinued operations | $11.2M | |||
| Total non-current assets | $9.1M | $14.2M | ||
| Total assets | $10.8M | $22.0M | ||
| Accounts payable | $1.2M | $2.4M | ||
| Short-term loans | $260.0K | $1.5M | ||
| Current maturities of long-term loans | $781.0K | $3.1M | ||
| Embedded derivatives | $29.0K | |||
| Short-term convertible loans | $867.0K | $779.0K | ||
| Other payables | $951.0K | $597.0K | ||
| Current liabilities of discontinued operations | $4.5M | |||
| Total current liabilities | $4.1M | $12.9M | ||
| Long-term loans, net of current maturities | $586.0K | $496.0K | ||
| Deferred taxes | $326.0K | $222.0K | ||
| Earn-out liability | $793.0K | |||
| Non-current liabilities of discontinued operations | $812.0K | |||
| Total non-current liabilities | $1.7M | $1.5M | ||
| Common stock of $0.0001 par value - Authorized: 490,000,000 shares; Issued and outstanding: 10,670,392 and 5,296,945 shares as of December 31, 2025, and December 31, 2024, respectively . | $4.0K | $3.0K | ||
| Additional paid-in capital | $51.0M | $28.5M | ||
| Accumulated deficit | -$46.0M | -$22.7M | ||
| Equity attributed to shareholders of Viewbix Inc. | $5.0M | $5.8M | ||
| Non-controlling interests | $1.7M | |||
| Total equity | $5.0M | $7.5M | $18.6M | |
| Total liabilities and shareholders equity | $10.8M | $22.0M | ||
| Common stock, par value | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 490.0M shares | 490.0M shares | ||
| Common stock, shares issued | 10.7M shares | 5.3M shares | ||
| Common stock, shares outstanding | 10.7M shares | 5.3M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $1.0M | $24.0K | ||
| Restricted deposits | $20.0K | $30.0K | ||
| Accounts receivable | $315.0K | $557.0K | ||
| Loan to parent company | $4.0M | |||
| Other current assets | $299.0K | $775.0K | ||
| Current assets of discontinued operations | $2.4M | |||
| Total current assets | $1.7M | $7.8M | ||
| Deferred taxes | $12.0K | $56.0K | ||
| Property and equipment, net | $56.0K | $17.0K | ||
| Financial assets measured at cost method | $600.0K | |||
| Intangible assets, net | $2.0M | $1.9M | ||
| Goodwill | $6.4M | $1.1M | ||
| Non-current assets of discontinued operations | $11.2M | |||
| Total non-current assets | $9.1M | $14.2M | ||
| Total assets | $10.8M | $22.0M | ||
| Accounts payable | $1.2M | $2.4M | ||
| Short-term loans | $260.0K | $1.5M | ||
| Current maturities of long-term loans | $781.0K | $3.1M | ||
| Embedded derivatives | $29.0K | |||
| Short-term convertible loans | $867.0K | $779.0K | ||
| Other payables | $951.0K | $597.0K | ||
| Current liabilities of discontinued operations | $4.5M | |||
| Total current liabilities | $4.1M | $12.9M | ||
| Long-term loans, net of current maturities | $586.0K | $496.0K | ||
| Deferred taxes | $326.0K | $222.0K | ||
| Earn-out liability | $793.0K | |||
| Non-current liabilities of discontinued operations | $812.0K | |||
| Total non-current liabilities | $1.7M | $1.5M | ||
| Common stock of $0.0001 par value - Authorized: 490,000,000 shares; Issued and outstanding: 10,670,392 and 5,296,945 shares as of December 31, 2025, and December 31, 2024, respectively . | $4.0K | $3.0K | ||
| Additional paid-in capital | $51.0M | $28.5M | ||
| Accumulated deficit | -$46.0M | -$22.7M | ||
| Equity attributed to shareholders of Viewbix Inc. | $5.0M | $5.8M | ||
| Non-controlling interests | $1.7M | |||
| Total equity | $5.0M | $7.5M | $18.6M | |
| Total liabilities and shareholders equity | $10.8M | $22.0M | ||
| Common stock, par value | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 490.0M shares | 490.0M shares | ||
| Common stock, shares issued | 10.7M shares | 5.3M shares | ||
| Common stock, shares outstanding | 10.7M shares | 5.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | $20.8M | $14.1M |
| Less: net loss from discontinued operations | $7.4M | $10.5M |
| Net loss from continuing operations | $13.4M | $3.6M |
| Depreciation and amortizations | $848.0K | $813.0K |
| Share-based compensation | $75.0K | $69.0K |
| Deferred taxes | -$68.0K | -$40.0K |
| Accrued interest, net | $23.0K | $33.0K |
| Interest income | -$63.0K | -$160.0K |
| Amortization of loan discounts | $38.0K | $59.0K |
| Change in the fair value of financial liabilities at fair value through profit or loss (see note 12) | $9.9M | -$11.0K |
| Amortization of deferred debt issuance costs (see notes 11.D, 11.E, 11.F) | $632.0K | $152.0K |
| Equity based debt issuance costs (see note 11.D) | $26.0K | |
| Loss from substantial debt terms modification (see note 11.C) | $1.9M | |
| Loss on sale and disposal of property and equipment | $73.0K | |
| Loss from termination of lease agreement | $8.0K | |
| Decrease in accounts receivable | $297.0K | $2.0M |
| Decrease (increase) in other current assets | -$153.0K | $319.0K |
| Decrease in accounts payable | -$1.2M | -$372.0K |
| Increase in other payables | $322.0K | $128.0K |
| Net cash provided by (used in) operating activities from continuing operations | -$2.8M | $1.4M |
| Net cash from acquisition of a subsidiary (see appendix A) | $12.0K | |
| Net cash from deconsolidation of a subsidiary (see appendix B) | -$163.0K | |
| Net cash used in investing activities from continuing operations | -$151.0K | |
| Receipt of short-term bank loans | $8.3M | $935.0K |
| Receipt of short-term convertible loans | $630.0K | $630.0K |
| Repayment of short-term bank loans | -$9.2M | -$3.3M |
| Receipt of a long-term bank loan (see note 11.B) | $1.6M | |
| Repayment of long-term bank loans | -$3.8M | -$510.0K |
| Increase in loan to parent company | -$4.0K | -$69.0K |
| Proceeds from issuance of shares and warrants in connection with 2024 Private Placement, net of issuance costs (see note 15.B) | $198.0K | |
| Proceeds from issuance of shares and warrants in connection with July 2025 Private Placement, net of issuance costs (see note 15.C) | $4.0M | |
| Proceeds from exercise of warrants | $2.2M | |
| Net cash provided by (used in) financing activities from continuing operations | $3.8M | -$2.1M |
| Net cash provided by (used in) operating activities from discontinued operations | -$694.0K | $143.0K |
| Net cash used in investing activities from discontinued operations | -$1.0K | |
| Net cash provided by (used in) financing activities from discontinued operations | $170.0K | -$670.0K |
| Net cash used in discontinued operations | -$524.0K | -$528.0K |
| Increase (decrease) in cash and cash equivalents and restricted cash | $356.0K | -$1.2M |
| Taxes paid | -$8.0K | -$123.0K |
| Interest paid | -$405.0K | -$676.0K |
| Total Cash paid during the period | -$413.0K | -$799.0K |
| Deemed extinguishment and re-issuance of debt (see note 11.C) | $500.0K | |
| Termination of operating lease agreement (see note 6) | $389.0K | |
| Redemption of loan to parent company (see note 17) | $4.0M | |
| Conversion of loans into shares and warrants (see notes 11.D, 11.E, 11.F) | $922.0K | |
| Investment in shares received in connection with deconsolidation of Cortex (see note 8.B) | $600.0K |
No quarter-by-quarter statement was filed.
Corporate structure
QUANTUM X LABS INC. sits at the top of its group. 5 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of QUANTUM X LABS INC.
- Nissim Daniel Filed SCHEDULE 13G/A on QUANTUM X LABS INC., latest Aug 20, 2026 (3 filings since Oct 22, 2025)
- L.I.A. Pure Capital Ltd Filed SCHEDULE 13G/A on QUANTUM X LABS INC., latest Aug 19, 2026 (4 filings since Feb 14, 2022)
- Capitalink Ltd. Filed SCHEDULE 13G/A on QUANTUM X LABS INC., latest May 15, 2026 (3 filings since Sep 18, 2024)
- MMCAP International Inc. SPC Filed SCHEDULE 13G/A on QUANTUM X LABS INC., latest Aug 12, 2025 (6 filings since Oct 6, 2022)
- M.R.M Merhavit Holding & Management Ltd Filed SC 13G on QUANTUM X LABS INC., latest Sep 18, 2024
- Gix Internet Ltd. Filed SC 13D/A on QUANTUM X LABS INC., latest Oct 3, 2022
- QUANTUM X LABS INC. Tel Aviv, Israel
- Emerald Medical Applications Ltd. Subsidiary · Israel
- Gix Media Ltd. Subsidiary · Israel
- VB Interactive Video Technologies Inc. Subsidiary · Delaware, United States
- Viewbix Ltd. Subsidiary · Israel
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What QUANTUM X LABS INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Properties, in its own words
Our principal executive offices are located at 3 Hanehoshet St, Building B, 7th floor, Tel Aviv, Israel 6971068, which we have been occupying since July 1, 2024. We pay a monthly fee of $5,400 for the lease of these offices, which we rent on a monthly basis.
In February 2026, we entered into a new lease agreement for office premises located at Atrium Tower, 2 Jabotinsky Street, Ramat Gan, Israel 5252903. The new facilities are expected to become available for occupancy on April 1, 2026. The lease term is for an initial period of six months, with an option to automatically extend for additional six month periods. The monthly rental payment will be NIS 16,500 (approximately $5,300).
Item 2 of the 10-K filed Mar 27, 2026.13
Leadership
Who has led QUANTUM X LABS INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
2010201520202025
- Chief executive officerYakov Baranes Jun 1, 2026 to now14
- Chief executive officerAmihay Hadad Dec 11, 2023 to Jun 1, 202615
- Chief executive officerJonathan Paul Stefansky Aug 13, 2019 to Aug 13, 201916
- Chief executive officerYair Fudim May 16, 2018 to May 16, 201817
- Chief executive officerLior Wayn Aug 28, 2015 to Aug 28, 201518
- Chief executive officerJehuda Maimon Nov 24, 2014 to Nov 24, 201419
- Chief executive officerIvo Heiden Mar 5, 2008 to Mar 7, 201320
- ChairYair Fudim May 16, 2018 to May 16, 201817
- ChairIvo Heiden Mar 5, 2008 to Feb 16, 201220
- Chief financial officerShahar Marom Sep 21, 2022 to now21
- Chief financial officerAmihay Hadad Aug 13, 2019 to Aug 13, 201922
- Chief financial officerGadi Levin May 16, 2018 to May 16, 201823
- Chief financial officerJehuda Maimon Nov 24, 2014 to Nov 24, 201419
- Chief financial officerIvo Heiden Apr 8, 2009 to Mar 7, 201324
- Chief operating officerHillel Joshua Scheinfeld Aug 13, 2019 to Aug 13, 201925
Board members and other officers (18)
- Board memberKineret Tzedef Jun 1, 2026 to now26
- Board memberRonen Rosenbloom Jun 1, 2026 to now27
- Board memberAmihay Hadad Dec 11, 2023 to now15
- Board memberAmitay Weiss Sep 21, 2022 to now28
- Board memberLiron Carmel Sep 21, 2022 to Sep 29, 202229
- Board memberYoram Baumann Sep 21, 2022 to now30
- Board memberEliyahu Yoresh Sep 29, 2022 to now31
- Board memberJonathan Paul Stefansky Aug 13, 2019 to Aug 13, 201916
- Board memberNoam Band Aug 13, 2019 to Aug 13, 201932
- Board memberAlon Dayan May 16, 2018 to Aug 13, 201933
- Board memberEyal Ben-Ami May 16, 2018 to May 16, 201834
- Board memberAlimi Ahmed Feb 2, 2017 to Feb 2, 201735
- Board memberBaruch Kfir Apr 7, 2016 to Apr 7, 201636
- Board memberYair Fudim Apr 8, 2016 to Apr 8, 201637
- Board memberLior Wayn Aug 28, 2015 to Aug 28, 201518
- Board memberEstery Giloz-Ran Oct 28, 2015 to Apr 4, 201638
- Board memberJehuda Maimon Nov 24, 2014 to Nov 24, 201419
- Board memberIvo Heiden Aug 20, 2008 to Mar 7, 201339
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Emerald Medical Applications Ltd. Israel4
- Gix Media Ltd. Israel4
- Quantum X Labs Ltd. Israel4
- VB Interactive Video Technologies Inc. Delaware4
- Viewbix Ltd. Israel4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
Timeline
- Sep 22, 20268-K Executive or director change40
- Sep 15, 20268-K Regulation FD disclosure; Other events41
- Jun 1, 2026New chief executive Yakov Baranes becomes CEO14
- May 29, 20268-K Other events42
- May 15, 20268-K Executive or director change43
- May 14, 20268-K Other events44
- Apr 30, 20268-K Bylaws or fiscal year changed; Regulation FD disclosure; Other events45
- Apr 21, 20268-K Regulation FD disclosure; Other events46
- Jan 2, 20268-K Entered a material agreement; Unregistered sale of shares47
- Dec 15, 20258-K Entered a material agreement; Unregistered sale of shares48
- Nov 14, 20258-K Other events49
- Nov 12, 20258-K Entered a material agreement50
- Nov 5, 20258-K Entered a material agreement; Unregistered sale of shares51
- Dec 11, 2023New chief executive Amihay Hadad becomes CEO15
- Aug 13, 2019New chief executive Jonathan Paul Stefansky becomes CEO16
- May 16, 2018New chief executive Yair Fudim becomes CEO17
- Aug 28, 2015New chief executive Lior Wayn becomes CEO18
- Nov 24, 2014New chief executive Jehuda Maimon becomes CEO19
- Mar 5, 2008New chief executive Ivo Heiden becomes CEO20
- Aug 16, 1985Founded QUANTUM X LABS INC. is founded2
Calendar
Coming up
- Nov 13, 2026Reports results for the quarter ending Sep/202652
When it reported results
- Aug 14, 2023Reported quarterly or annual results53
- May 15, 2023Reported quarterly or annual results54
- Mar 24, 2023Reported quarterly or annual results55
- Nov 22, 2022Reported quarterly or annual results56
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
152 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 43 major events, 30 insider forms, 18 large holders, 1 private raises, 39 other. The latest 20:
- Sep 22, 20268-K EDGAR
- Sep 17, 20264 EDGAR
- Sep 15, 20268-K EDGAR
- Aug 24, 20264 EDGAR
- Aug 20, 2026SCHEDULE 13G/A EDGAR
- Aug 19, 2026SCHEDULE 13G/A EDGAR
- Aug 13, 202610-Q EDGAR
- Jun 29, 2026SEC STAFF ACTION EDGAR
- Jun 1, 20264 EDGAR
- Jun 1, 20263 EDGAR
- Jun 1, 20263 EDGAR
- Jun 1, 20264 EDGAR
- Jun 1, 20263 EDGAR
- May 29, 20268-K EDGAR
- May 15, 20268-K EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 15, 2026SCHEDULE 13G/A EDGAR
- May 14, 202610-Q EDGAR
- May 14, 20268-K EDGAR
The 152 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
11 open-market trades by officers, directors and large owners since October 2021: 10 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Baranes YakovCo-CEO | Buy | 5,000 | $4.88 | $24.4K | Form 4 |
| Aug 21, 2026 | Yoresh EliyahuDirector | Buy | 4,500 | $4.77 | $21.5K | Form 4 |
| Mar 31, 2026 | Weiss AmitayDirector | Sale | 30,296 | $2.00 | $60.6K | Form 4 |
| Mar 4, 2026 | Yoresh EliyahuDirector | Buy | 179,159 | Form 4 | ||
| Sep 3, 2025 | Yoresh EliyahuDirector | Buy | 260,000 | $1.00 | $260.0K | Form 4 |
| Jul 11, 2025 | Yoresh EliyahuDirector | Buy | 5,144 | $4.86 | $25.0K | Form 4 |
| Jun 18, 2024 | Yoresh EliyahuDirector | Buy | 2,518 | $1.00 | $2.5K | Form 4 |
| Jun 18, 2024 | Marom ShaharChief Financial Officer | Buy | 1,259 | $1.00 | $1.3K | Form 4 |
| Jun 18, 2024 | Baumann YoramDirector | Buy | 9,444 | $1.00 | $9.4K | Form 4 |
| Jun 18, 2024 | Weiss AmitayDirector | Buy | 2,518 | $1.00 | $2.5K | Form 4 |
| Jun 18, 2024 | Hadad AmihayChief Executive Officer | Buy | 2,518 | $1.00 | $2.5K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Nissim DanielSCHEDULE 13G/A, 3 filings Oct 22, 2025 to Aug 20, 202657
- L.I.A. Pure Capital LtdSCHEDULE 13G/A, 4 filings Feb 14, 2022 to Aug 19, 202658
- Capitalink Ltd.SCHEDULE 13G/A, 3 filings Sep 18, 2024 to May 15, 202659
- MMCAP International Inc. SPCSCHEDULE 13G/A, 6 filings Oct 6, 2022 to Aug 12, 202560
- M.R.M Merhavit Holding & Management LtdSC 13G, 1 filing Sep 18, 202461
- Gix Internet Ltd.SC 13D/A, 1 filing Oct 3, 202262
Money raised
Private offerings the company reported to the SEC on Form D.
- Jul 11, 2025Raised $8.9 million in a private offering of equity Form D: 12 investors so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| MMCAP International Inc. SPC | 361,573 | $2.1M | 0.2% | +245,578 |
| UBS Group AG | 13,266 | $75.6K | 0.0% | +12,002 |
| XTX Topco Ltd | 11,498 | $65.5K | 0.0% | New |
| Morgan Stanley | 100 | $570 | 0.0% | New |
| Hrt Financial LP | 43,819 | $249 | 0.0% | New |
| Bank Hapoalim Bm | 20,000 | $114 | 0.0% | New |
| Caitong International Asset Management Co., Ltd | 10 | $57 | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How QUANTUM X LABS INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARQUANTUM X LABS INC.1
- CIK0000797542
- Employer ID (EIN)68-008060113
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; a shell company13
- Incorporated inDelaware13
- Fiscal year endsDecember 311
- Industry code (SIC)7372 Services-Prepackaged Software1
- SEC reviewing officeOffice of Technology, Division of Corporation Finance1
- Business address2 Jabotinsky St, Atrium Tower, 18Th Floor, Ramat Gan, 5252903, Israel1
- Phone855-879-84391
- Shares outstanding13,336,392 shares as of Mar 26, 202613
- Public float$20.8M as of Jun 30, 202513
- AuditorBrightman Almagor Zohar & Co., Tel Aviv, Israel PCAOB ID 1197; it also attests to the company’s internal control over financial reporting13
- On EDGAR sinceMay 15, 19961
- Filings465 in all: 8-K (102), 10-Q (56), 3 (38), 10QSB (36), 4 (25), UPLOAD (20), 10-K (18), CORRESP (16)1
All 48 form types
NT 10-Q (16), 5 (15), DEF 14C (9), PRE 14C (9), NT 10-K (8), SCHEDULE 13G/A (8), 10KSB (7), 10-Q/A (6), 8-K/A (6), S-1/A (6), 10KSB40 (5), S-1 (5), 10KSB/A (4), DEF 14A (4), EFFECT (4), SC 13G (4), 3/A (3), RW (3), SC 13G/A (3), SCHEDULE 13G (3), 10KSB40/A (2), 424B3 (2), D (2), DEFA14C (2), PRE 14A (2), S-3 (2), 10QSB/A (1), 8-A12B (1), 8-K12G3 (1), 8-K12G3/A (1), CERT (1), DEL AM (1), NT 10-K/A (1), PRER14C (1), SB-2 (1), SB-2/A (1), SC 13D (1), SC 13D/A (1), SC 14F1 (1), SEC STAFF ACTION (1)
- Latest filingsAnnual report (10-K) Mar 27, 2026
Quarterly report (10-Q) Aug 13, 2026
Proxy statement (DEF 14A) Jul 20, 2000
Latest 8-K (8-K) Sep 22, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.0001 per share | VBIX | Nasdaq |
From the cover page of the 10-K filed Mar 27, 2026 (Section 12(b) of the Exchange Act).13
Risk factors and legal proceedings
The risks QUANTUM X LABS INC. names in Item 1A of its 10-K filed Mar 27, 2026: 64 risks under these headings, as written.13
- Risks Associated with Our Business and Industry
- Risks Related to our Competition
- Risks Related to our Intellectual Property
- Risks Related to Data Protection Regulation
- Risks Related to Our Investment in Quantum Computing
- Risks Related to Our Common Stock
- Risks Related to our Operations in Israel
- Our success depends, in part, upon the continued demand of digital advertising as an integral part of corporate marketing and internal communications plans and the continued growth and acceptance of digital content as effective alternatives to traditional offline marketing products and services.
- Online platform updates, including operating systems, search engines, browsers and social media might affect our ability to generate revenues, temporarily or permanently.
- Should the providers of internet browsers, advertisement platforms and Search Engines further regulate, constrain or limit our ability to offer advertising services, or materially change their guidelines, technology or the way they operate, our ability to generate revenue from advertising could be significantly reduced.
- Large and established internet and technology companies, such as Google, Facebook and Amazon, play a substantial role in the digital advertising market and may significantly harm our ability to operate in this industry.
- The use of third-party software solutions for the purpose of blocking ads and / or alerts may cause our business to suffer.
The other 59 risks
- We depend on supply sources to provide us with advertising inventory in order for us to deliver advertising campaigns in a cost-effective manner.
- A significant portion of our revenue is concentrated with one customer.
- Our Search Platform depends heavily upon revenue generated from the material agreement with our Gix Major Customer, and any adverse change in that agreement could adversely affect our business, financial condition and results of operations.
- Reliance upon material suppliers may adversely affect our revenue and operating results.
- We may not be able to receive credit facility to fund our operations, on favorable terms, or at all.
- We may be unable to pay our obligations when they become due, including under the Financing Agreement.
- Our success is dependent on the preferences of consumers, internet users and advertisers.
- A loss of the services of our technology vendors could adversely affect the execution of our business strategy.
- The report of our independent registered public accounting firm contains an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern, which could prevent us from obtaining new financing on reasonable terms or at all.
- Large and established internet and technology companies, such as Google and Facebook, play a substantial role in the digital advertising market and may significantly impair our ability to operate in this industry.
- The digital advertising market is highly competitive. If we cannot compete effectively in this market, our revenues are likely to decline.
- Our implementation and use of artificial intelligence technologies may not be successful, which may impair our ability to compete effectively, result in reputational harm and have an adverse effect on our business.
- If we cannot enforce and protect our intellectual property rights, our business could be adversely affected.
- We may in the future be subject to claims of intellectual property infringement that could adversely affect our business.
- Patent terms may be inadequate to protect our competitive position for an adequate amount of time.
- We may not be able to protect our systems, technology and infrastructure from cyberattacks.
- A failure in our technology infrastructure may adversely affect our business and financial condition and disrupt our customers’ businesses.
- Our business depends on our ability to collect and use data, and any limitation on the collection and use of this data could significantly diminish the value of our platforms and cause us to lose customers and revenue.
- Regulations, legislation, or self-regulation developments relating to privacy, data collection and protection and internet advertising, and uncertainties regarding the application or interpretation of existing or newly adopted laws and regulations, could harm our business and subject us to significant legal liability for non-compliance.
- We rely on third-party Internet, mobile, and other products and services to deliver our mobile and web applications to users, and any disruption of, or interference with, our use of those services could adversely affect our business, financial condition, results of operations, and customers.
- As the regulatory framework for artificial intelligence evolves, including with respect to unintentional bias and discrimination, our business, financial condition, and results of operations may be adversely affected.
- Risks Related to Quantum X Labs’ Status as an Early-Stage Company
- Quantum X Labs is an early-stage company and has a limited operating history, which makes it difficult to forecast its future results of operations.
- Quantum X Labs may not be able to scale its business quickly enough to meet customer and market demand, which could adversely affect its financial condition and results of operations or cause us to fail to execute on its business strategies.
- Quantum X Labs’ estimates of market opportunity and forecasts of market growth may prove to be inaccurate.
- Even if the market in which Quantum X Labs competes achieves the forecasted growth, its business could fail to grow at similar rates, if at all.
- Risks Related to Quantum X Labs’ Business and Industry
- If its quantum computing technologies are not compatible with some or all industry-standard software and hardware in the future, its business could be harmed.
- If its technology fail to achieve a broad quantum advantage, its business, financial condition and future prospects may be harmed.
- An element of its business is currently dependent upon its relationship with its cloud providers. There are no assurances that Quantum X Labs will be able to commercialize quantum computers from its relationships with cloud providers.
- The quantum computing and networking industry is competitive on a global scale and Quantum X Labs may not be successful in competing in this industry or establishing and maintaining confidence in its long-term business prospects among current and future partners and customers.
- The quantum computing and networking industry is in its early stages and volatile, and if it does not develop, if it develops slower than Quantum X Labs expects, if it develops in a manner that does not require use of its quantum computing solutions, if it encounters negative publicity or if its solution does not drive commercial engagement, the growth of its business will be harmed.
- Quantum X Labs may to face supply chain issues that could delay the introduction of its product and negatively impact its business and operating results.
- If Quantum X Labs cannot successfully execute on its strategy, including in response to changing customer needs and new technologies and other market requirements, or achieve its objectives in a timely manner, its business, financial condition and results of operations could be harmed.
- If Quantum X Labs is unable to maintain its current strategic partnerships or Quantum X Labs is unable to develop future collaborative partnerships, its future growth and development could be negatively impacted.
- Quantum X Labs’ business depends on its customers’ abilities to implement useful quantum algorithms and sufficient quantum resources for their business. If they are unable to do so, including due to their algorithmic challenge or other technical or personnel dilemmas, its growth may be negatively impacted.
- Quantum X Labs is highly dependent on its key employees who have specialized knowledge, and its ability to attract and retain senior management and other key employees is critical to its success.
- Quantum X Labs’ future growth and success depends in part on its ability to sell effectively to government entities and large enterprises.
- Risks Related to Quantum X Labs’ Intellectual Property
- If Quantum X Labs is unable to obtain and maintain effective intellectual property rights for its products, Quantum X Labs may not be able to compete effectively in its markets.
- Intellectual property rights of third parties could adversely affect its ability to commercialize its products, and Quantum X Labs might be required to litigate or obtain licenses from third parties in order to develop or market its product candidates. Such litigation or licenses could be costly or not available on commercially reasonable terms.
- Patent policy and rule changes could increase the uncertainties and costs surrounding the prosecution of its patent applications and the enforcement or defense of any issued patents.
- Quantum X Labs may be involved in lawsuits to protect or enforce its intellectual property, which could be expensive, time consuming, and unsuccessful.
- Quantum X Labs may be subject to claims challenging the inventorship of its intellectual property.
- Quantum X Labs may not be able to protect its intellectual property rights throughout the world.
- Quantum X Labs may become subject to claims for remuneration or royalties for assigned service invention rights by its employees, which could result in litigation and adversely affect its business.
- Raising additional capital or the issuance of additional equity securities would cause dilution to our existing stockholders and may affect the rights of existing stockholder or the market price of our common stock.
- A more active, liquid trading market for our common stock may not develop, and the price of our common stock may fluctuate significantly.
- We are subject to compliance with securities law, which exposes us to potential liabilities, including potential rescission rights.
- We have never paid cash dividends and do not anticipate doing so in the foreseeable future.
- We incur significant increased costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives.
- We are a smaller reporting company and, as a result of the reduced disclosure and governance requirements applicable to such companies, our common stock may be less attractive to investors.
- Shares of common stock eligible for future sale may adversely affect the market.
- If we fail to maintain compliance with the Nasdaq minimum listing requirements, our common stock will be subject to delisting. Our ability to publicly or privately sell equity securities and the liquidity of our common stock could be adversely affected if our common stock delisted.
- Our share price has fluctuated significantly and could continue to fluctuate significantly.
- Delaware law contains provisions that could discourage, delay or prevent a change in control of our Company, prevent attempts to replace or remove current management and reduce the market price of our stock.
- Were our common stock to become subject to the penny stock rules then this could result in U.S. broker-dealers becoming discouraged from effecting transactions in shares of our common stock.
- Scrutiny of sustainability and environmental, social, and governance initiatives could increase our costs or otherwise adversely impact our business.
- Our business, operating results and growth rates may be adversely affected by current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk.
- Conditions in Israel, including Israel’s conflicts with Hamas and other parties in the region, as well as political and economic instability, may impede our ability to operate and harm our financial results.
- Exchange rate fluctuations between foreign currencies and the U.S. Dollar may negatively affect our earnings.
- It may be difficult to enforce a judgment of a U.S. court against us, our officers and directors or the Israeli experts named in our reports filed with the SEC in Israel or the United States, to assert U.S. securities laws claims in Israel or to serve process on our officers and directors and these experts.
Legal proceedings
We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of the Company, threatened against or affecting the Company, our common stock, our officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.
The opening of Item 3, Legal Proceedings.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARYair Fudim, Chief executive officer
- 18SEC EDGARLior Wayn, Chief executive officer
- 19
- 20SEC EDGARIvo Heiden, Chief executive officer
- 21
- 22
- 23SEC EDGARGadi Levin, Chief financial officer
- 24SEC EDGARIvo Heiden, Chief financial officer
- 25
- 26SEC EDGARKineret Tzedef, Board member
- 27SEC EDGARRonen Rosenbloom, Board member
- 28SEC EDGARAmitay Weiss, Board member
- 29SEC EDGARLiron Carmel, Board member
- 30SEC EDGARYoram Baumann, Board member
- 31SEC EDGAREliyahu Yoresh, Board member
- 32SEC EDGARNoam Band, Board member
- 33SEC EDGARAlon Dayan, Board member
- 34SEC EDGAREyal Ben-Ami, Board member
- 35SEC EDGARAlimi Ahmed, Board member
- 36SEC EDGARBaruch Kfir, Board member
- 37SEC EDGARYair Fudim, Board member
- 38SEC EDGAREstery Giloz-Ran, Board member
- 39SEC EDGARIvo Heiden, Board member
- 40SEC EDGARExecutive or director change
- 41
- 42SEC EDGAROther events
- 43SEC EDGARExecutive or director change
- 44SEC EDGAROther events
- 45
- 46
- 47
- 48
- 49SEC EDGAROther events
- 50SEC EDGAREntered a material agreement
- 51
- 52NasdaqNasdaq calendar
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62